David M. Mott
Director · NOVAVAX INC
IndividualBuying only
- 2024
- Jun 23, 2026
- 14
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David M. Mott files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael Raab - $2.57M in ARDX purchases and sales in the last 12 months
- Laura A. Williams - $659K in ARDX purchases and sales in the last 12 months
- Eric Duane Foster - $176K in ARDX purchases and sales in the last 12 months
- Mike Kelliher - $162K in ARDX purchases and sales in the last 12 months
- Joseph James Reilly - $129K in ARDX purchases and sales in the last 12 months
- John E. Bishop - $109K in ARDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David M. Mott?
David M. Mott is a corporate insider, tracked as Director of NOVAVAX INC (NVAX). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David M. Mott last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 14 filings going back to 2024.
Has David M. Mott been buying or selling stock?
Recorded transactions: 7 open-market purchases ($7.34M) and 0 open-market sales across all tracked filings.
